Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 January 2019 | Story Thabo Kessah | Photo Thabo Kessah
Dr Lisa Komoreng
Dr Lisa Komoreng’s research highlights traditional medicinal plant qualities used to deal with diseases like TB and elephantiasis.

The burden that diseases like tuberculosis (TB), lymphatic filariasis (elephantiasis), sexually transmitted infections (STIs), skin infections, and ear, nose and throat (ENT) infections bring to the country, mainly poverty-stricken communities, has prompted Dr Lisa Komoreng to focus her research on traditional medicinal plants.

 

South Africa, says Dr Komoreng, has the third highest number of reported cases and the fifth highest number of estimated prevalent cases, with the second highest burden of drug-resistant TB cases in the world amongst the 22 high-burden countries.

South Africa is burdened
by elephantiasis and treating
it remains a huge problem,
says Dr Lisa Komoreng.

 

“According to the Free State Provincial Strategic Plan (2012-2016), HIV and TB are the leading causes of death in the Province, with TB being the second most leading cause. Our country is also burdened by elephantiasis and treating it remains a huge problem. Patients are often turned away from some of the public hospitals, reasons being that there is no treatment in the country or that the disease needs specialist care. It with this in mind that my research focuses on providing treatment that is cheaper than western medicine, easily accessible, with fewer or no side effects,” she said.

 

“People suffering from elephantiasis are not only physically disabled, but they suffer mental, social and financial losses contributing to stigma and poverty. Some of the drugs used to treat the disease are ineffective against adult parasitic worms, which are the ones that cause the disease, and they also have side effects. Our research in dealing with these diseases enables us to work hand-in-hand with herbalists, traditional healers and people who have indigenous knowledge about the use of traditional medicine. We consult with them in order to acquire information about the medicinal plants that are used to treat and manage those diseases. Once they provide us with information, we collect the plant species together, which we subsequently take to the University herbarium for proper identification of their scientific names and to the laboratory for experiments,” she added.

 

Dr Komoreng is a Senior Lecturer in the Department of Plant Sciences at the Qwaqwa Campus. She has authored and co-authored over 15 research articles and has presented her research at various national and international conferences.  Her research team comprises of 5 MSc and 4 PhD students.

 

The Thuthuka NRF Rating Track (2015 – 2017 and 2018 – 2020) funds the research project on elephantiasis.

News Archive

International medical symposium
2011-06-10

 
Left to right, Dr  S.M Mogaladi from Pretoria, Dr Paul Sergeant, Chairperson of the International Cooperation Committee of the European Association of Cardiothoracic Surgery ( also immediate past president of EACTS) and Dr Richard Schulenburg from our university.

Our Faculty of Health Sciences hosted the European Association for Cardiothoracic Surgeons Academy (EACTS) and Hannes Meyer Cardiothoracic Surgery Registrar Symposium, from 3 to 5 June 2011.

The focus of this year’s symposium was new techniques in perfusion and surgery, with specific emphasis on research methodology, inflammatory lung disease and cardiac surgery in children and adults, which can be performed without the aid of a heart-lung machine in developing countries. 

The symposium was attended by approximately 70 delegates from cardiothoracic units from across South Africa and 10 doctors from 6 African countries, as well as 30 perfusion technologists.

Several international visitors were present, like Prof. Paul Sergeant and Prof. Marko Turina, two previous EACTS presidents and Prof. Charles Yankah, a Ghanaian Cardiothoracic Surgeon from the Charite Medical University in Berlin. The current president of the European Board of Cardiovascular Perfusion (EBCP), Mr Frank Merkle, was also one of three international speakers delivering lectures on perfusion technology.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept